phenylbutazone has been researched along with scopolamine hydrobromide in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Constantin, M; Duchêne-Marullaz, P; Talvard, J | 1 |
| Bauer, BJ; Brodie, DA; Cook, PG; Dagle, GE | 1 |
| Calhoun, FJ; Schrogie, JJ; Tolson, WW | 1 |
| McMartin, C; Street, HV | 1 |
8 other study(ies) available for phenylbutazone and scopolamine hydrobromide
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
[Influence of several anticholinergic agents on digestive hemorrhages induced by phenylbutazone].
Topics: Animals; Atropine; Chromium Isotopes; Erythrocytes; Feces; Gastric Juice; Gastrointestinal Hemorrhage; Phenylbutazone; Rats; Scopolamine | 1970 |
Indomethacin-induced intestinal lesions in the rat.
Topics: Administration, Oral; Animals; Antacids; Aspirin; Atropine; Bile Ducts; Bretylium Compounds; Chlorpromazine; Cholestyramine Resin; Cyproheptadine; Food Deprivation; Indomethacin; Injections, Subcutaneous; Intestinal Diseases; Intestinal Fistula; Intestinal Perforation; Intestine, Small; Male; Pentobarbital; Peptic Ulcer; Phenylbutazone; Rats; Scopolamine; Starvation; Time Factors | 1970 |
Effects of various drugs on the uterotropic response to mestranol and norethynodrel in the rat.
Topics: Aminosalicylic Acids; Animals; Chlorpromazine; Drug Synergism; Female; Imipramine; Mestranol; Norethynodrel; Organ Size; Phenobarbital; Phenylbutazone; Phenytoin; Proadifen; Rats; Scopolamine; Tolbutamide; Uterus | 1971 |
Gas-liquid chromatography of submicrogram amounts of drugs. I. Preparation, scope and limitation of columns.
Topics: Acetaminophen; Amphetamine; Caffeine; Chlordiazepoxide; Chromatography, Gas; Cyclizine; Morphine; Phenelzine; Phenylbutazone; Salicylates; Scopolamine; Secobarbital; Trifluoperazine | 1966 |